| SCHRODER ISF EMERGING ASIA B ACC EUR | RVI ASIA | 46,63% | 42,36% | 22,28% | 160,61% |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 46,62% | 4,13% | -34,58% | · |
| BGF WORLD FINANCIALS X2 USD | FINANCIERO | 46,59% | 129,09% | 119,29% | · |
| GOLDMAN SACHS GLOBAL FUTURE ECONOMIC SECURITY EQUITY PORTFOLIO P USD DIS | RVI GLOBAL | 46,59% | · | · | · |
| MSIF ASIA EQUITY Z (USD) | RVI ASIA EX-JAPÓN | 46,59% | 66,21% | 48,53% | · |
| AMUNDI CORE MSCI EMERGING MARKETS AE CAP | RVI EMERGENTES | 46,58% | 56,16% | 33,15% | · |
| BGF ASIAN GROWTH LEADERS D2 CHF (HEDGED) | RVI ASIA EX-JAPÓN | 46,58% | 47,90% | 13,68% | 89,64% |
| UBS MSCI EM INDEX FUND EUR A ACC | RVI EMERGENTES | 46,58% | · | 33,75% | · |
| CT (LUX) RESPONSIBLE GLOBAL EMERGING MARKETS EQUITY A USD ACC | RVI EMERGENTES | 46,57% | 43,43% | 20,31% | · |
| HSBC GIF ASIA EX JAPAN EQUITY BC USD | RVI ASIA EX-JAPÓN | 46,57% | 52,22% | 10,69% | · |
